Case of psoriatic erythroderma induced by the discontinuation of the chronic use of topical steroid after dialysis initiation and successfully treated with secukinumab

J Dermatol. 2019 Apr;46(4):e119-e120. doi: 10.1111/1346-8138.14649. Epub 2018 Sep 19.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Cutaneous
  • Adrenal Insufficiency / diagnosis
  • Adrenal Insufficiency / etiology*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Biopsy
  • Dermatitis, Exfoliative / diagnosis
  • Dermatitis, Exfoliative / pathology
  • Dermatitis, Exfoliative / therapy*
  • Disease Progression
  • Female
  • Glucocorticoids / adverse effects*
  • Humans
  • Middle Aged
  • Psoriasis / diagnosis
  • Psoriasis / pathology
  • Psoriasis / therapy*
  • Renal Dialysis
  • Severity of Illness Index
  • Skin / drug effects
  • Skin / pathology
  • Time Factors
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Glucocorticoids
  • secukinumab